InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: flubber post# 240518

Monday, 01/13/2020 10:22:25 AM

Monday, January 13, 2020 10:22:25 AM

Post# of 425915

@ dancinginthedark @ ratna1


quote:

"Acasti Pharma Inc. (ACST) shares dropped 54% to $1 after the company reported topline results for the primary endpoint, triglyceride reduction at 12 and 26 weeks, from its Phase 3 Trilogy 1 trial for its lead product candidate, CaPre, came in close to the placebo arm.

The biopharmaceutical company said the study showed a 30.5% median reduction in triglyceride levels among all patients receiving CaPre, compared with a 27.5% median reduction in triglyceride levels among patients receiving placebo at 12 weeks. "
________________________________________________________________________

quote:

"Cannot vouch for my memory being 100% correct but I do seem to recall that STREGTH also used corn oil as placebo. Maybe you are not in the dark but on to something!"
________________________________________________________________________



HOW DO I INVEST IN CORN OIL & CORN STARCH FUTURES????
Looks like the placebo works fairly well!




it cannot have been just corn starch in a capsule, correct? had to be suspended in something oil like? I have not seen a capsule of capre, but its contents are not strictly powder, are they?

It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News